₹719.75
-7.75 (-1.07%)
As of 22 Sept 2026, Astec Lifesciences Ltd share price is ₹719.75. The stock opened at ₹719.75 and had closed at ₹727.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹512.35 and a high of ₹936.00. In terms of performance, Astec Lifesciences Ltd share price has increased by 37.83% over the past six months and has decreased by 13.21% over the last year.
ASTEC Stock Price Chart
Astec Lifesciences Ltd Overview
Market cap₹1,604 Crs
Volume1,889
Prev. Close₹727.50
Year range₹512.35 - ₹936.00
ISININE563J01010
About ASTEC
Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.
Astec Lifesciences Ltd Historical Performance
1 Month Return19.42%
6 Month Return28.30%
3 Year Return-45.18%
3 Month Return-7.69%
1 Year Return-14.92%
5 Year Return-45.61%
Astec Lifesciences Ltd Fundamentals
ROCE(TTM)-5.55%
P/E Ratio (TTM)-24.05
P/B Ratio4.11
Debt to Equity1.15
ROE-20.78%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value174.96
Profit Margin-14.66%
Operating Margin-8.80%
Astec Lifesciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 453.14 | 386.86 | 463.76 | 641.21 | 687.03 |
| EBITDA | -1.61 | -60.64 | -0.33 | 89.30 | 164.55 |
| Net Profit | -81.01 | -134.81 | -46.99 | 25.52 | 89.82 |
| EPS | -37.83 | -68.74 | -23.96 | 13.02 | 45.85 |
Astec Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 706.65 |
| Resistance 1 (R1) | 759.70 |
| Pivot Point | 738.85 |
Astec Lifesciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 21-Jul-2023 | 02-May-2023 | 22-Jul-2023 | Final | ₹1.50 |
| 19-Jul-2022 | 02-May-2022 | 21-Jul-2022 | Final | ₹1.50 |
| 22-Jul-2021 | 30-Apr-2021 | 24-Jul-2021 | Final | ₹1.50 |
ASTEC Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Vishal Sharma | Chairman |
| Ashok V Hiremath | Non Executive Independent Director |
| Sunil Kataria | Non Executive Independent Director |
Astec Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| UPL LtdUPL | ₹559.90-3.47% | ₹51,802.16 | 25.84 | 5.54% |
| P I Industries LtdPIIND | ₹2,321.80-1.90% | ₹46,368.09 | 31.96 | 11.76% |
| Sumitomo Chemical India LtdSUMICHEM | ₹454.55-1.37% | ₹19,746.21 | 37.15 | 16.02% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Astec Lifesciences Ltd today is ₹719.75 on NSE and ₹719.75 on BSE.
- The 52-week high of Astec Lifesciences Ltd is ₹936.00, while the 52-week low is ₹512.35.
- The current market capitalisation of Astec Lifesciences Ltd is approximately ₹1,604 crore.
- The P/E (Price-to-Earnings) ratio of Astec Lifesciences Ltd is -15.98. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Astec Lifesciences Ltd is 3.44. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Astec Lifesciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ASTEC on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Astec Lifesciences Ltd has delivered a return of approximately -45.18%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Astec Lifesciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 71.96% promoters, -3.02% FIIs, 3.33% DIIs, and 20.48% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
